Aion Therapeutic Appoints New CRO Amid Board Change
Company Announcements

Aion Therapeutic Appoints New CRO Amid Board Change

Story Highlights

Aion Therapeutic Inc (TSE:AION) has released an update.

Aion Therapeutic Inc. has appointed Charles Freihofer as the new Chief Revenue Officer for its subsidiary, Toppen Health, to drive revenue growth and enhance market presence. The company also announced the resignation of director Larry Horwitz. Freihofer’s extensive experience in sales and marketing is expected to bolster the company’s mission to provide clean water solutions worldwide.

For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAion Therapeutic’s New Private Placement Offering
TipRanks Canadian Auto-Generated NewsdeskAion Therapeutic Inc. Reports on Financial Filing Delay
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App